HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 96 filers reported holding HARVARD BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,265 | -33.5% | 4,015 | -15.1% | 0.00% | – |
| Q2 2023 | $25,963 | +8.2% | 4,729 | +22.8% | 0.00% | – |
| Q1 2022 | $24,000 | -11.1% | 3,851 | 0.0% | 0.00% | – |
| Q4 2021 | $27,000 | 0.0% | 3,851 | 0.0% | 0.00% | – |
| Q3 2021 | $27,000 | -15.6% | 3,851 | 0.0% | 0.00% | – |
| Q2 2021 | $32,000 | +77.8% | 3,851 | +15.6% | 0.00% | – |
| Q1 2021 | $18,000 | +28.6% | 3,330 | 0.0% | 0.00% | – |
| Q4 2020 | $14,000 | +40.0% | 3,330 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | -33.3% | 3,330 | -30.4% | 0.00% | – |
| Q2 2020 | $15,000 | +50.0% | 4,782 | -8.5% | 0.00% | – |
| Q2 2019 | $10,000 | -56.5% | 5,226 | 0.0% | 0.00% | – |
| Q1 2019 | $23,000 | +35.3% | 5,226 | 0.0% | 0.00% | – |
| Q4 2018 | $17,000 | -37.0% | 5,226 | 0.0% | 0.00% | – |
| Q3 2018 | $27,000 | -3.6% | 5,226 | 0.0% | 0.00% | – |
| Q2 2018 | $28,000 | – | 5,226 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,053,907 | $8,626,409 | 9.88% |
| B. Riley Asset Management, LLC | 3,408,796 | $14,316,943 | 5.93% |
| Meros Investment Management, LP | 1,124,206 | $4,721,665 | 2.69% |
| Harvey Partners, LLC | 2,712,700 | $11,393,340 | 1.41% |
| Archon Capital Management LLC | 1,361,769 | $5,719,430 | 1.28% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,947,329 | $12,378,782 | 0.80% |
| BARD ASSOCIATES INC | 291,297 | $1,223,448 | 0.50% |
| Portolan Capital Management | 1,043,546 | $4,382,893 | 0.42% |
| HEARTLAND ADVISORS INC | 1,200,000 | $5,040,000 | 0.31% |
| EAM Investors, LLC | 345,546 | $1,451,293 | 0.28% |